Galapagos NV (AMS:GLPG)
Netherlands · Delayed Price · Currency is EUR 26.68
-0.28 (-1.04%)
Nov 4, 2025, 10:42 AM CET
Galapagos NV Employees
Galapagos NV had 704 employees as of December 31, 2024. The number of employees decreased by 419 or -37.31% compared to the previous year.
Employees
704
Change (1Y)
-419
Growth (1Y)
-37.31%
Revenue / Employee
€493,923
Profits / Employee
€509,452
Market Cap
1.78B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 704 | -419 | -37.31% |
| Dec 31, 2023 | 1,123 | -215 | -16.07% |
| Dec 31, 2022 | 1,338 | 29 | 2.22% |
| Dec 31, 2021 | 1,309 | -180 | -12.09% |
| Dec 31, 2020 | 1,489 | 486 | 48.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Galapagos NV News
- 11 days ago - Galapagos to Present In Vitro Data at ACR Convergence 2025 Suggesting Differentiation of GLPG3667 from Other TYK2 Inhibitors - GlobeNewsWire
- 12 days ago - RBC Capital Raises Price Target on Galapagos (GLPG) to $28.00 | GLPG Stock News - GuruFocus
- 13 days ago - Galapagos (GLPG) Stock Upgraded by Leerink Partners | GLPG Stock News - GuruFocus
- 13 days ago - Galapagos (GLPG) Stock Outlook Brightens with Analyst Upgrade - GuruFocus
- 13 days ago - Galapagos (GLPG) to Discontinue Cell Therapy Unit, Shares Fall - GuruFocus
- 13 days ago - GILD: Galapagos Plans to Wind Down Cell Therapy Operations - GuruFocus
- 14 days ago - Biotech firm Galapagos to wind down cell therapy business - Reuters
- 14 days ago - Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company's Ongoing Transformation - Benzinga